Structure-guided discovery and engineering of miniature CRISPR-Cas12m for epigenome editing.
Yu, T., Ji, M., Yu, D., Guan, Z., Zhu, R., Jiang, Y., Yang, Z., Qiu, L., Zhang, Z., Mu, J., Mao, F., Xiang, K., Bai, L., Li, K.(2026) Nat Struct Mol Biol 
- PubMed: 42749924 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1038/s41594-026-01890-9
- Primary Citation Related Structures: 
9WZR - PubMed Abstract: 
CRISPR-based epigenome editing represents a programmable strategy to precisely modulate gene expression, holding promise for therapeutic applications. However, the large size of dCas proteins substantially impedes delivery using adeno-associated virus (AAV) vectors. Here, through iterative bioinformatics analysis, structure-guided predictions and functional assays, we identified and characterized a miniature subtype V-M CRISPR-Cas12m from Pelomicrobium methylotrophicum. PmCas12m exhibited flexible 5'-YTN-3' PAM-dependent recognition and robust double-stranded DNA-binding properties while lacking DNA cleavage activity, thus rendering it a valuable tool for epigenome editing. Cryo-electron microscopy structures of PmCas12m unveiled its molecular mechanism of target DNA binding. Guided by these structural insights, we used deep mutational scanning and protein engineering to develop xCas12m, a hypercompact variant with highly potent and specific epigenome-editing capabilities in human cells. We further constructed the xCas12m-CRISPRoff platform in a single AAV vector, which achieved durable epigenetic silencing and effective inhibition of hepatitis B virus infection in a mouse model. Collectively, these findings establish xCas12m as a versatile epigenome-editing platform with notable potential for treating diseases, paving the way for clinical translation of epigenetic therapies.
- Department of Biochemistry and Molecular Biology, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Organizational Affiliation: 




